IGF2BP3 and liver cancer: Survival analysis using Kaplan-Meier curves derived from the TCGA database indicated that high IGF2BP3 expression was associated with reduced survival times only in liver cancer patients, while no significant differences were noted for the other three types of gastrointestinal cancers.